290 related articles for article (PubMed ID: 1321284)
1. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
[TBL] [Abstract][Full Text] [Related]
2. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
Kabrun N; Hodgson JW; Doemer M; Mak G; Franza BR; Enrietto PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1783-7. PubMed ID: 1848011
[TBL] [Abstract][Full Text] [Related]
4. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
Gélinas C; Temin HM
Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
[TBL] [Abstract][Full Text] [Related]
5. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
Ballard DW; Walker WH; Doerre S; Sista P; Molitor JA; Dixon EP; Peffer NJ; Hannink M; Greene WC
Cell; 1990 Nov; 63(4):803-14. PubMed ID: 2225078
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
Morrison LE; Boehmelt G; Enrietto PJ
Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
[TBL] [Abstract][Full Text] [Related]
7. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
Morrison LE; Boehmelt G; Beug H; Enrietto PJ
Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
La Rosa FA; Pierce JW; Sonenshein GE
Mol Cell Biol; 1994 Feb; 14(2):1039-44. PubMed ID: 8289784
[TBL] [Abstract][Full Text] [Related]
9. The Rel family: models for transcriptional regulation and oncogenic transformation.
Bose HR
Biochim Biophys Acta; 1992 Sep; 1114(1):1-17. PubMed ID: 1327144
[No Abstract] [Full Text] [Related]
10. The N-terminal env-derived amino acids of v-rel are required for full transforming activity.
Garson K; Percival H; Kang CY
Virology; 1990 Jul; 177(1):106-15. PubMed ID: 2162102
[TBL] [Abstract][Full Text] [Related]
11. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
Mosialos G; Hamer P; Capobianco AJ; Laursen RA; Gilmore TD
Mol Cell Biol; 1991 Dec; 11(12):5867-77. PubMed ID: 1944267
[TBL] [Abstract][Full Text] [Related]
12. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
13. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
Ballard DW; Dixon EP; Peffer NJ; Bogerd H; Doerre S; Stein B; Greene WC
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1875-9. PubMed ID: 1542686
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
Hrdlicková R; Nehyba J; Bose HR
J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
[TBL] [Abstract][Full Text] [Related]
15. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
16. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
Schatzle JD; Kralova J; Bose HR
J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
[TBL] [Abstract][Full Text] [Related]
17. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
Kieran M; Blank V; Logeat F; Vandekerckhove J; Lottspeich F; Le Bail O; Urban MB; Kourilsky P; Baeuerle PA; Israël A
Cell; 1990 Sep; 62(5):1007-18. PubMed ID: 2203531
[TBL] [Abstract][Full Text] [Related]
18. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
Diehl JA; Hannink M
J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
[TBL] [Abstract][Full Text] [Related]
19. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
Sif S; Capobianco AJ; Gilmore TD
Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
[TBL] [Abstract][Full Text] [Related]
20. I kappa B alpha-mediated inhibition of v-Rel DNA binding requires direct interaction with the RXXRXRXXC Rel/kappa B DNA-binding motif.
Kumar S; Gélinas C
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8962-6. PubMed ID: 8415639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
